Author:
Karran Eric,Mercken Marc,Strooper Bart De
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference150 articles.
1. Golde, T. E., Petrucelli, L. & Lewis, J. Targeting Aβ and tau in Alzheimer's disease, an early interim report. Exp. Neurol. 223, 252–266 (2010).
2. Ness, D. K. et al. Reduced β-amyloid burden, increased C-99 concentrations and evaluation of neuropathology in the brains of PDAPP mice given LY450139 dihydrate daily by gavage for 5 months. Neurobiol. Aging 25, S238–S239 (2004).
3. Bateman, R. J. et al. A γ-secretase inhibitor decreases amyloid-β production in the central nervous system. Ann. Neurol. 66, 48–54 (2009).
4. Lanz, T. A. et al. Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, LY-450139. J. Pharmacol. Exp. Ther. 319, 924–933 (2006).
5. Wakabayashi, T. & De Strooper, B. Presenilins: members of the γ-secretase quartets, but part-time soloists too. Physiology (Bethesda) 23, 194–204 (2008).
Cited by
1826 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献